The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994 · cited 1×
“The lipid hydroperoxides can undergo various reactions and rearrangements forming aldehydes, specifically malondialdehyde, 4-hydroxynonenal, or acrolein[27].”
BackgroundApolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
NMDA-dependent superoxide production and neurotoxicity
Lafon-Cazal, M., Pietri, S., Culcasi, M., & Bockaert, J. (1993) · Nature · doi:10.1038/364535a0 · Cited by 1,183
Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationAmyloid β-Protein and the Genetics of Alzheimer's Disease
Selkoe, D. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18295 · Cited by 799
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1×
“Predictably, GS has decreased activity in AD brain [30].”
BackgroundMark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 779
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 735
Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity
Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735
Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis
Kruman, I., Bruce-Keller, A. J., Bredesen, D., Waeg, G., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-13-05089.1997 · Cited by 723
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., & Barnham, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100175200 · Cited by 649
Lovell, M. A., Ehmann, W. D., Butler, S. M., & Markesbery, W. R. (1995) · Neurology · doi:10.1212/wnl.45.8.1594 · Cited by 644
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationCastegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Self-citationMark, R., Hensley, K., Butterfield, D., & Mattson, M. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06239.1995 · Cited by 558
Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., & Mattson, M. P. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-01046.1997 · Cited by 551 · cited 3×
“By disrupting Ca2+ homeostasis [55], reducing Na+/K+-ATPase activity[53,55], and imparing glucose transport [56], HNE is neurotoxic to rat hippocampal neurons.”
BackgroundIncreased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
Marcus, D. L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. S., Strafaci, J. A., & Freedman, M. L. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6750 · Cited by 513
Modification of histidine residues in proteins by reaction with 4-hydroxynonenal.
Uchida, K., & Stadtman, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4544 · Cited by 491
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464
Self-citationAutopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro
Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 439
Butterfield, D. A., & Kanski, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00249-4 · Cited by 419
Butterfield, D. A., Hensley, K., Harris, M., Mattson, M., & Carney, J. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1508 · Cited by 404
Protein‐Bound Acrolein: A Novel Marker of Oxidative Stress in Alzheimer's Disease
Calingasan, N. Y., Uchida, K., & Gibson, G. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720751.x · Cited by 400
Chapter 7 Protein Oxidation Processes in Aging Brain
Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390
Butterfield, D. A. (1997) · Chemical Research in Toxicology · doi:10.1021/tx960130e · Cited by 364
Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. E., Wyss-Coray, T., Mucke, L., & Mahley, R. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04867.1999 · Cited by 360
Advances in Alzheimer's disease
Katzman, R., & Saitoh, T. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.2001787 · Cited by 357
Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., & Mattson, M. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00065-1 · Cited by 357
Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354
Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35)
Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010452r · Cited by 346
Self-citationEvidence for Synaptic Apoptosis
Mattson, M. P., Keller, J. N., & Begley, J. G. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6863 · Cited by 340
(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330
Glutamate Transporters in Neurologic Disease
Maragakis, N. J., & Rothstein, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.365 · Cited by 324
Current Status of Acrolein as a Lipid Peroxidation Product
Uchida, K. (1999) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(99)00016-x · Cited by 301
Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease
Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275
Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270
Ramassamy, C., Averill, D., Beffert, U., Bastianetto, S., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Davignon, J., Quirion, R., et al. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00102-1 · Cited by 241
Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease
Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J. (1998) · Annals of Neurology · doi:10.1002/ana.410440322 · Cited by 239
Guan, Z., Wang, Y., Cairns, N. J., Lantos, P. L., Dallner, G., & Sindelar, P. J. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00008 · Cited by 236
Montine, K. S., Olson, S. J., Amarnath, K., Whetsell, W. O., Graham, D. G., & Montine, T. J. (1997) · Europe PMC (PubMed Central) · Cited by 231
Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Chemistry and pathophysiology of oxidation of LDL
Esterbauer, H., & Ramos, P. (1995) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0048264 · Cited by 199
Phospholipase A2s and lipid peroxidation
Nigam, S., & Schewe, T. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00119-0 · Cited by 196
Evidence of an oxidative challenge in the Alzheimer's brain
Balazs, L., & Leon, M. (1994) · Neurochemical Research · doi:10.1007/bf00965146 · Cited by 196
Oxidative Insults Are Associated with Apolipoprotein E Genotype in Alzheimer's Disease Brain
Ramassamy, C., Averill, D., Beffert, U., Theroux, L., Lussier-Cacan, S., Cohn, J. S., Christen, Y., Schoofs, A., Davignon, J., & Poirier, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0273 · Cited by 195
Butterfield, D. A., Hensley, K., Cole, P., Subramaniam, R., Aksenov, M., Aksenova, M., Bummer, P. M., Haley, B. E., & Carney, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062451.x · Cited by 191
Bruce‐Keller, A. J., Begley, J. G., Fu, W., Butterfield, D. A., Bredesen, D. E., Hutchins, J. B., Hensley, K., & Mattson, M. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010031.x · Cited by 188
Reich, E. E., Markesbery, W. R., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63968-5 · Cited by 183
Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M., & Allan Butterfield, D. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00012-2 · Cited by 183
Self-citationBruns, C. M., Hubatsch, I., Ridderström, M., Mannervik, B., & Tainer, J. A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2697 · Cited by 180
Butterfield, D. A., & Kański, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00066-9 · Cited by 173
Apolipoprotein E and Alzheimer's Disease A Role in Amyloid Catabolism
POIRIER, J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05564.x · Cited by 171
Methionine residue 35 is important in amyloid β-peptide-associated free radical oxidative stress
Varadarajan, S., Yatin, S., Kanski, J., Jahanshahi, F., & Butterfield, D. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00093-3 · Cited by 169
Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease
Palmer, A. M., & Burns, M. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91670-5 · Cited by 168
Koppal, T., Drake, J., Yatin, S., Jordan, B., Varadarajan, S., Bettenhausen, L., & Butterfield, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720310.x · Cited by 167
Self-citationPocernich, C. B., La Fontaine, M., & Butterfield, D. A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00126-6 · Cited by 165
Oxidative Regulation of Fatty Acid-Induced Tau Polymerization
Gamblin, T. C., King, M. E., Kuret, J., Berry, R. W., & Binder, L. I. (2000) · Biochemistry · doi:10.1021/bi001876l · Cited by 159
4-Hydroxy-2-Nonenal Pyrrole Adducts in Human Neurodegenerative Disease
MONTINE, K. S., KIM, P. J., OLSON, S. J., MARKESBERY, W. R., & MONTINE, T. J. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00004 · Cited by 158
Montine, K. S., Reich, E. E., Neely, M. D., Sidell, K. R., Olson, S. J., Markesbery, W. R., & Montine, T. J. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00005 · Cited by 153
Apolipoprotein E Isoform-Specific Differences in Outcome from Focal Ischemia in Transgenic Mice
Sheng, H., Laskowitz, D. T., Bennett, E. R., Schmechel, D. E., Bart, R. D., Saunders, A. M., Pearlstein, R. D., Roses, A. D., & Warner, D. S. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199804000-00003 · Cited by 152
Lauderback, C. M., Kański, J., Hackett, J. M., Maeda, N., Kindy, M. S., & Butterfield, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03228-0 · Cited by 149
Self-citationMasliah, E., Samuel, W., Veinbergs, I., Mallory, M., Mante, M., & Saitoh, T. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01420-5 · Cited by 146
Pedersen, W. A., Chan, S. L., & Mattson, M. P. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741426.x · Cited by 144
Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 139
Bruce‐Keller, A. J., Li, Y., Lovell, M. A., Kraemer, P. J., Gary, D. S., Brown, R. R., Markesbery, W. R., & Mattson, M. P. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199803000-00007 · Cited by 133
Banks, W. A., Farr, S. A., Butt, W. R., Kumar, V. B., Franko, M. W., & Morley, J. E. (2001) · PubMed · Cited by 126
Fontaine, M. A. L., Geddes, J. W., Banks, A., & Butterfield, D. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751709.x · Cited by 118
Montine, T. J., Markesbery, W. R., Zackert, W. E., Sanchez, S. C., Roberts, L. J., & Morrow, J. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65185-1 · Cited by 115
Harris‐White, M. E., Carney, J. M., Cole, P. S., Hensley, K., Howard, B. J., Martin, L., Bummer, P. M., Wang, Y., Pedigo, N. W., & Butterfield, D. A. (1995) · Neuroreport · doi:10.1097/00001756-199510020-00013 · Cited by 112
Avdulov, N. A., Chochina, S. V., Igbavboa, U., O‘Hare, E., Schroeder, F., Cleary, J. P., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052086.x · Cited by 106
Mason, R. P., Estermyer, J. D., Kelly, J. F., & Mason, P. E. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0699 · Cited by 105
Butterfield, D. A., Yatin, S. M., Varadarajan, S., & Koppal, T. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09050-3 · Cited by 99
Kański, J., Aksenova, M. V., Schöneich, C., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00821-3 · Cited by 97
Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures
Beffert, U., Aumont, N., Dea, D., Lussier‐Cacan, S., Davignon, J., & Poirier, J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00073-x · Cited by 94
Oxidative Modification of Glutamine Synthetase by Amyloid Beta Peptide
Aksenov, M. Y., Aksenova, M. V., Carney, J. M., & Butterfield, D. A. (1997) · Free Radical Research · doi:10.3109/10715769709065765 · Cited by 88
In Vitro31P NMR Spectroscopy Detects Altered Phospholipid Metabolism in Alzheimer's Disease
Miatto, O., González, R. G., Buonanno, F. S., & Growdon, J. H. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037276 · Cited by 86
Maor, I., Kaplan, M., Hayek, T., Vaya, J., Hoffman, A., & Aviram, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2359 · Cited by 83
Koppal, T., Subramaniam, R., Drake, J., Prasad, M. R., Dhillon, H. S., & Butterfield, D. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01466-2 · Cited by 77
Self-citationYang, D.-S., Small, D. H., Seydel, U., Smith, J. D., Hallmayer, J., Gandy, S. E., & Martins, R. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00561-2 · Cited by 76
Guo, Z. H., & Mattson, M. P. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7497 · Cited by 72
Apolipoprotein E allele–dependent antioxidant activity in brains with Alzheimer’s disease
Tamaoka, A., Miyatake, F., Matsuno, S., Ishii, K., Nagase, S., Sahara, N., Ono, S., Mori, H., Wakabayashi, K., Tsuji, S., et al. (2000) · Neurology · doi:10.1212/wnl.54.12.2319 · Cited by 70
Schöneich, C., Zhao, F., Madden, K. P., et al. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a012 · Cited by 68
Lauderback, C. M., Hackett, J. M., Keller, J. N., Varadarajan, S., Szweda, L. I., Kindy, M. S., Markesbery, W. R., & Butterfield, D. A. (2001) · Biochemistry · doi:10.1021/bi002312k · Cited by 67
Self-citationIncreased 3-nitrotyrosine in brains of Apo E-deficient mice
Matthews, R. T., & Beal, M. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01576-0 · Cited by 62
Kański, J., Aksenova, M. V., & Butterfield, D. A. (2002) · Neurotoxicity Research · doi:10.1080/10298420290023945 · Cited by 60
Elevated glutathione as a therapeutic strategy in Alzheimer's disease
Butterfield, D. A., Pocernich, C. B., & Drake, J. (2002) · Drug Development Research · doi:10.1002/ddr.10095 · Cited by 58
Self-citationPraticò, D., Rokach, J., & Tangirala, R. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730736.x · Cited by 55
Characterization of 8‐Epiprostaglandin F2α as aMarker of Amyloid β‐Peptide‐Induced Oxidative Damage
Mark, R. J., Fuson, K. S., & May, P. C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721146.x · Cited by 54
Koppal, T., Drake, J., & Butterfield, D. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00014-9 · Cited by 52
Self-citationSelley, M. L. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00446-x · Cited by 50
Montine, T. J., Montine, K. S., Olson, S. J., Graham, D. G., Roberts, L. J., Morrow, J. D., Linton, M. F., Fazio, S., & Swift, L. L. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7067 · Cited by 38
Van Uden, E., Sagara, Y., Van Uden, J., Orlando, R., Mallory, M., Rockenstein, E., & Masliah, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001151200 · Cited by 35
Cited by
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
“Double bonds of unsaturated fatty acids are hot spots for attack by free radicals those initiate cascade or chain reaction to damage neighboring unsaturated fatty acids [13].”
BackgroundAntioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869
Metadata
- Authors
- ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 23
- Issue
- 5
- Pages
- 655-664
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2115978010
- Cited by
- 715
- References
- 102
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.